Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Thursday, December 2
11:30 -11:50 AM
FDLI Welcome and Opening Presentation
April Inyard Alexandrow, Science and Policy Coordinator, FDA Cannabis Product Committee, Office of the Commissioner, FDA
Amy Comstock Rick, President & CEO, FDLI
Enter this session: https://fdli.zoom.us/j/82834794801
12:00 – 1:00 PM
Present and Future Federal Marijuana Policies and Interplay with State Regulatory Frameworks
Mark Bolton, Head of Global Public Policy, Jazz Pharmaceuticals, Inc.
Andrew Freedman, Senior Vice President, Forbes Tate Partners
Andrew J. Kline, Senior Counsel, Perkins Coie LLP
Moderated by William Garvin, Shareholder, Buchanan Ingersoll & Rooney PC
Enter this session: https://fdli.zoom.us/j/88605455923
1:10 – 2:10 PM
How States are Responding to Marijuana’s Public Health Concerns and Implications for Possible Federal Regulation
James T. O’Reilly, Volunteer Professor, University of Cincinnati School of Medicine
Gillian L. Schauer, Executive Director, Cannabis Regulators Association
George Sam Wang, Associate Professor of Pediatrics, Section of Emergency Medicine and Medical Toxicology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado
Moderated by Deborah Miran, Consultant, DMiran Consulting
Enter this session: https://fdli.zoom.us/j/86771429860
2:10 – 2:40 PM
Break
2:40 – 3:40 PM
State and Federal Marijuana Policies: Addressing Racial Bias and Social Equity Reform
John Hudak, Deputy Director, Center for Effective Public Management, The Brookings Institution
Danielle K. Perry, Cannabis Regulation Oversight Officer, State of Illinois
Shawn “Pepper” Roussel, Attorney at Law, Green Pepper Solutions
Alyssa Samuel, Attorney, Husch Blackwell LLP
Enter this session: https://fdli.zoom.us/j/85174716086
3:50 – 4:35 PM
International Cannabis Regulation: Impact and Considerations for a U.S. Framework
Eileen McMahon, Partner, Torys LLP
Joseph Wyse, Head of Patent Department, Dr. Eyal Bressler & Co. Ltd.
Moderated by Jessica Wasserman, Partner, WassermanRowe LLC and Chair, Science and Regulatory Affairs Committee, Council for Federal Cannabis Regulation (CFCR)
Enter this session: https://fdli.zoom.us/j/82627743387
4:45 – 5:45 PM
The Hazy Legal Status of Synthetic Cannabinoids
Edgar J. Asebey, Partner, Keller Asebey Life Science Law PLLC
Brad Douglass, Independent Consultant, EAS Consulting Group
Howard R. Sklamberg, Partner, Arnold & Porter LLP
Moderated by Thomas Tobin, Associate, Perkins Coie LLP
Enter this session: https://fdli.zoom.us/j/89706684044